메뉴 건너뛰기




Volumn 28, Issue 5, 2001, Pages 461-464

The bisphosphonate zoledronate decreases type II collagen breakdown in patients with Paget's disease of bone

Author keywords

Bisphosphonate; Cartilage; Osteoarthritis; Paget's disease; Rheumatoid arthritis; Type II collagen

Indexed keywords

BIOCHEMICAL MARKER; COLLAGEN TYPE 2; PEPTIDE; PLACEBO; ZOLEDRONIC ACID;

EID: 0035049894     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(01)00431-8     Document Type: Article
Times cited : (55)

References (15)
  • 2
    • 0005107667 scopus 로고    scopus 로고
    • Christgau, S., Garnero, P., Fledelius, C., Jensen, T., Moniz, M., Ensig, M., Cloos, P., Gineyts, E., Rosenquist, C., and Qvist, P. Collagen type II C-telopeptide fragments as an index of cartilage degradation. Bone. In press.
  • 5
    • 0005150425 scopus 로고    scopus 로고
    • Fleish, H. Bisphosphonates: Mechanisms of action and clinical use. In: Bilezikian, J. P., Raisz, L. G., and Rodan, G. A., Eds. Principles of Bone Biology. San Diego, CA: Academic, 1996;1037-1052.
  • 6
    • 0018595947 scopus 로고
    • Comparative anti-inflammatory and bone protective effects of two diphosphonates in adjuvant arthritis
    • (1979) Arthritis Rheum , vol.22 , pp. 340-346
    • Flora, L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.